Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 20 phantom stock units through the Pfizer Supplemental Savings Plan on April 30, 2024.

Summary

• On April 30, 2024, Albert Bourla, the Chairman and CEO of Pfizer Inc., acquired 20 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The price of the derivative security was $25.62.
• Following the transaction, Bourla directly owns 659,681 shares of common stock.
• These units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of an insider transaction, with no inherent positive or negative implications.

Positives

• The acquisition of phantom stock units by the CEO demonstrates his continued investment in the company's future.
• The Pfizer Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives of publicly traded companies. It provides transparency into the investment activities of key personnel and their alignment with shareholder interests.

Comparison to Industry Standards

• Executive compensation packages often include stock options, restricted stock units (RSUs), or phantom stock units to align management's interests with those of shareholders.
• Companies like Johnson & Johnson (JNJ) and Merck (MRK) also utilize similar equity-based compensation plans for their executives.
• The specific terms and conditions of these plans, such as vesting schedules and settlement methods, can vary widely across companies and industries.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency to shareholders regarding the CEO's investment in the company.

Key Dates